Medgenics (MDGN) Misses Q3 EPS by 31c
Tweet
Share
E-mailGet Alerts MDGN Hot Sheet
Join SI Premium – FREE
Medgenics (NYSE: MDGN) reported Q3 EPS of ($0.66), $0.31 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Medgenics (MDGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Kotak Upgrades Persistent Systems Ltd. (PSYS:IN) to Buy (1)
- Integra LifeSciences cuts 2026 outlook after Cincinnati flood
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
